Get the Stockscreener App
5.11
1.54%
-0.08
After Hours:
5.10
-0.01
-0.20%
Arcadia Biosciences Inc Stock (RKDA) Forecast
The Arcadia Biosciences Inc (RKDA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $51.61, representing a +910.02% increase from the current price of $5.11. The highest analyst price target is $85.81, and the lowest is $17.41.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RKDA Price Target
Average 43.36
(+748.53% Upside)
Is Arcadia Biosciences Inc (RKDA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.59 | Neutral |
| STOCH(9,6) | 79.27 | Neutral |
| STOCHRSI(14) | 64.27 | Neutral |
| MACD(12,26) | -0.0464 | Sell |
| ADX(14) | 20.72 | Neutral |
| William %R | -20.22 | Neutral |
| CCI(14) | 5.9558 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.1106
Sell
|
5.1527
Sell
|
| MA20 |
5.2923
Sell
|
5.2289
Sell
|
| MA50 |
4.8959
Buy
|
4.9637
Buy
|
| MA100 |
4.113
Buy
|
4.40
Buy
|
| MA200 |
3.4256
Buy
|
3.8143
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, RKDA could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on RKDA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 47.59 indicates that RKDA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 79.27 indicates that RKDA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.27 indicates that RKDA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.72 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 5.9558 indicates that RKDA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RKDA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arcadia Biosciences Inc financial reports and earnings history, Arcadia Biosciences Inc (RKDA) stock could reach $186.54 by 2030, $130.50 by 2040 and $411.95 by 2050. See the projected annual prices until 2050 of the Arcadia Biosciences Inc stock below:
- Arcadia Biosciences Inc (RKDA) is expected to reach an average price of $39.10 in 2035, with a high prediction of $44.03 and a low estimate of $39.29. This indicates an $665.18% rise from the last recorded price of $5.11.
- Arcadia Biosciences Inc (RKDA) stock is projected to chart a bullish course in 2040, with an average price target of $126.47, representing an $2,375% surge from its current level. The forecast ranges from a conservative $126.90 to a sky-high $130.50.
- Our analysts predict Arcadia Biosciences Inc (RKDA) to jump 4,712% by 2045, soaring from $245.27 to an average price of $245.91, potentially reaching $245.64. While $245.27 is the low estimate, the potential upside is significant.
- Arcadia Biosciences Inc (RKDA) stock is expected to climb by 2050, reaching an average of $388.55, a $7,504% jump from its current level. However, a wide range of estimates exists, with high and low targets of $411.95 and $392.95, respectively, highlighting the market's uncertainty.
Arcadia Biosciences Inc Stock (RKDA) Year by Year Forecast
Arcadia Biosciences Inc Stock (RKDA) Price Forecast for 2025
Arcadia Biosciences Inc Stock (RKDA) is expected to reach an average price of $44.32 in 2025, with a high prediction of $87.73 and a low estimate of $0.9099. This indicates an +767.32% rise from the last recorded price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $31.41 | $17.41 | $85.81 | +514.68% |
| March, 2025 | $5.8699 | $8.8901 | $45.05 | +14.87% |
| April, 2025 | $53.27 | $21.19 | $49.43 | +942.46% |
| May, 2025 | $4.5499 | $16.95 | $47.79 | -10.96% |
| June, 2025 | $8.2299 | $0.9099 | $50.91 | +61.05% |
| July, 2025 | $21.57 | $10.03 | $32.57 | +322.12% |
| August, 2025 | $4.1099 | $0.9499 | $38.25 | -19.57% |
| September, 2025 | $4.1899 | $10.23 | $4.0501 | -18.01% |
| October, 2025 | $27.19 | $22.31 | $22.67 | +432.09% |
| November, 2025 | $34.87 | $29.03 | $28.87 | +582.38% |
| December, 2025 | $26.27 | $17.23 | $29.79 | +414.09% |
Arcadia Biosciences Inc Stock (RKDA) Price Forecast for 2026
The predicted value for Arcadia Biosciences Inc (RKDA) in 2026 is set at an average of $62.06. Estimates vary from a peak of $123.41 to a trough of $0.7097, indicating an +1,114% surge from the present price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.6418 | $23.55 | $14.63 | +49.55% |
| February, 2026 | $36.83 | $9.2698 | $12.03 | +620.74% |
| March, 2026 | $12.11 | $30.91 | $30.42 | +136.98% |
| April, 2026 | $14.89 | $2.4902 | $123.41 | +191.39% |
| May, 2026 | $13.19 | $11.23 | $14.37 | +158.12% |
| June, 2026 | $20.87 | $24.47 | $16.75 | +308.41% |
| July, 2026 | $23.87 | $18.91 | $21.79 | +367.12% |
| August, 2026 | $2.7498 | $9.1458 | $8.0502 | -46.19% |
| September, 2026 | $8.1497 | $0.7097 | $10.33 | +59.49% |
| October, 2026 | $18.23 | $13.07 | $16.31 | +256.75% |
| November, 2026 | $14.71 | $20.35 | $18.07 | +187.86% |
| December, 2026 | $25.31 | $19.23 | $22.79 | +395.30% |
Arcadia Biosciences Inc Stock (RKDA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arcadia Biosciences Inc (RKDA) is $42.42, with a high forecast of $59.40 and a low forecast of $25.43. This indicates an +730.05% increase from the last price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $28.99 | $25.43 | $23.03 | +467.31% |
| February, 2027 | $37.07 | $28.03 | $22.15 | +625.43% |
| March, 2027 | $57.27 | $46.79 | $49.27 | +1,021% |
| April, 2027 | $55.35 | $56.95 | $54.19 | +983.16% |
| May, 2027 | $57.53 | $59.07 | $59.40 | +1,026% |
| June, 2027 | $41.63 | $51.83 | $52.99 | +714.67% |
| July, 2027 | $31.71 | $31.59 | $21.47 | +520.54% |
| August, 2027 | $40.19 | $29.83 | $37.39 | +686.49% |
| September, 2027 | $27.59 | $33.59 | $42.15 | +439.91% |
| October, 2027 | $34.87 | $29.03 | $27.39 | +582.38% |
| November, 2027 | $35.35 | $37.03 | $36.03 | +591.77% |
| December, 2027 | $29.95 | $37.15 | $36.51 | +486.10% |
Arcadia Biosciences Inc Stock (RKDA) Price Forecast for 2028
In 2028, Arcadia Biosciences Inc (RKDA) is projected to reach an average price of $41.43, with a high projection of $48.63 and a low estimate of $34.23. This indicates an +710.75% rise from the last price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $36.08 | $36.87 | $34.43 | +606.10% |
| February, 2028 | $46.19 | $39.26 | $43.71 | +803.98% |
| March, 2028 | $47.07 | $46.03 | $48.63 | +821.13% |
| April, 2028 | $48.87 | $49.19 | $48.55 | +856.35% |
| May, 2028 | $46.51 | $46.87 | $46.55 | +810.17% |
| June, 2028 | $41.18 | $41.87 | $45.30 | +705.90% |
| July, 2028 | $38.85 | $41.18 | $41.09 | +660.27% |
| August, 2028 | $40.74 | $40.31 | $40.00 | +697.25% |
| September, 2028 | $38.88 | $38.88 | $39.84 | +660.85% |
| October, 2028 | $37.19 | $37.90 | $38.05 | +627.78% |
| November, 2028 | $35.29 | $35.50 | $36.63 | +590.60% |
| December, 2028 | $33.51 | $34.23 | $34.43 | +555.76% |
Arcadia Biosciences Inc Stock (RKDA) Price Forecast for 2029
The 2029 price forecast for Arcadia Biosciences Inc Stock (RKDA) is $82.72 on average, with a high prediction of $164.70 and a low estimate of $0.7493. This represents an +1,519% increase from the previous price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $29.65 | $29.69 | $32.29 | +480.22% |
| February, 2029 | $27.67 | $27.77 | $28.64 | +441.48% |
| March, 2029 | $24.88 | $25.15 | $26.77 | +386.88% |
| April, 2029 | $22.69 | $22.86 | $24.26 | +344.02% |
| May, 2029 | $19.29 | $19.38 | $21.62 | +277.53% |
| June, 2029 | $16.83 | $16.96 | $18.45 | +229.32% |
| July, 2029 | $13.86 | $14.29 | $15.29 | +171.22% |
| August, 2029 | $11.20 | $11.25 | $13.20 | +119.17% |
| September, 2029 | $8.0994 | $8.0994 | $10.33 | +58.50% |
| October, 2029 | $5.2194 | $5.3194 | $7.1895 | +2.14% |
| November, 2029 | $2.6894 | $2.8982 | $4.3894 | -47.37% |
| December, 2029 | $199.90 | $0.7493 | $164.70 | +3,812% |
Arcadia Biosciences Inc Stock (RKDA) Price Forecast for 2030
Arcadia Biosciences Inc Stock (RKDA) is expected to reach an average price of $203.10 in 2030, with a high forecast of $297.42 and a low forecast of $108.78. This signifies an +3,875% surge from the last price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $250.70 | $204.03 | $186.54 | +4,806% |
| February, 2030 | $267.26 | $254.06 | $261.82 | +5,130% |
| March, 2030 | $305.42 | $271.90 | $297.42 | +5,877% |
| April, 2030 | $74.78 | $108.78 | $186.06 | +1,363% |
| May, 2030 | $186.78 | $118.62 | $170.78 | +3,555% |
| June, 2030 | $173.34 | $180.54 | $182.46 | +3,292% |
| July, 2030 | $181.74 | $177.02 | $179.50 | +3,457% |
| August, 2030 | $131.10 | $139.90 | $149.18 | +2,466% |
| September, 2030 | $142.46 | $130.54 | $120.62 | +2,688% |
| October, 2030 | $152.06 | $153.10 | $148.86 | +2,876% |
| November, 2030 | $222.22 | $186.14 | $195.02 | +4,249% |
| December, 2030 | $223.18 | $222.54 | $218.06 | +4,268% |
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):